Sodium oligomannate capsules | China Drugs List
Public reference information, not medical advice, a prescription or an offer to supply a medicine. Confirm current approval, availability and suitability with licensed professionals.
- Brand
- Jiuqiyi
- Company
- Shanghai Green Valley Pharmaceuticals
- Medicine type
- Chemical medicine
- Therapeutic area
- Neurology
- Indications recorded in the public source
- For mild-to-moderate Alzheimer's disease, to improve cognitive function.
- Indication source and scope
- 2021-09-29
- Prescribing-information limitations
- Complete official prescribing information obtained. Mainland China label.
- China availability status
- Historical Chinese approval verified; current continuous market availability has not been checked for every product.
- Overseas status
- Market-by-market verification pending.
- Insurance classification
- Not matched in the 2025 national list; manual review pending
- Insurance edition
- 2025 edition; effective 1 January 2026
- Insurance verification notes
- No match in the extracted directory is not proof of exclusion. Compound formulations still require manual review.
Sources
- https://mpa.xinjiang.gov.cn/xjyjj/gjjdt/201911/90b884f07b3643e1aa491cfa1cc293d8.shtml
- https://www.nhsa.gov.cn/module/download/downfile.jsp?classid=0&filename=a32f9f2f3fc046afaf08471f87456ce3.pdf
- https://www.gv-971.com/Public/Uploads/uploadfile/files/20220324/geshigongchangPicPDFproduct-~2.pdf
Open the interactive record, public price references and discussions